Moneycontrol PRO
Loans
HomeNewsGlenmarkpharma
Jump to
  • Buy Glenmark Pharma; target of Rs 2400: Motilal Oswal

    Motilal Oswal is bullish on Glenmark Pharma has recommended buy rating on the stock with a target price of Rs 2400 in its research report dated August 18, 2025.

  • Sell Glenmark Pharmaceuticals; target of Rs 1570: ICICI Securities

    Sell Glenmark Pharmaceuticals; target of Rs 1570: ICICI Securities

    ICICI Securities is bearish on Glenmark Pharmaceuticals has recommended sell rating on the stock with a target price of Rs 1570 in its research report dated August 19, 2025.

  • Sell Glenmark Pharmaceuticals; target of Rs 1620: ICICI Securities

    Sell Glenmark Pharmaceuticals; target of Rs 1620: ICICI Securities

    ICICI Securities is bearish on Glenmark Pharmaceuticals has recommended sell rating on the stock with a target price of Rs 1620 in its research report dated July 18, 2025.

  • Buy Glenmark Pharma; target of Rs 2430: Motilal Oswal

    Buy Glenmark Pharma; target of Rs 2430: Motilal Oswal

    Motilal Oswal is bullish on Glenmark Pharma recommended buy rating on the stock with a target price of Rs 2430 in its research report dated July 11, 2025.

  • Buy Glenmark Pharma; target of Rs 1690: Motilal Oswal

    Buy Glenmark Pharma; target of Rs 1690: Motilal Oswal

    Motilal Oswal is bullish on Glenmark Pharma recommended buy rating on the stock with a target price of Rs 1690 in its research report dated May 26, 2025.

  • Buy Glenmark Pharmaceuticals; target of Rs 1768: KR Choksey

    Buy Glenmark Pharmaceuticals; target of Rs 1768: KR Choksey

    KR Choksey is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1768 in its research report dated February 18, 2025.

  • Buy Glenmark Pharmaceuticals; target of Rs 1894: KR Choksey

    Buy Glenmark Pharmaceuticals; target of Rs 1894: KR Choksey

    KR Choksey is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1894 in its research report dated November 18, 2024.

  • Reduce Glenmark Pharmaceuticals: target of Rs 1345: ICICI Securities

    Reduce Glenmark Pharmaceuticals: target of Rs 1345: ICICI Securities

    ICICI Securities recommended reduce rating on Glenmark Pharmaceuticals with a target price of Rs 1345 in its research report dated August 16, 2024.

  • Buy Glenmark Pharma; target of Rs 1850: Motilal Oswal

    Buy Glenmark Pharma; target of Rs 1850: Motilal Oswal

    Motilal Oswal is bullish on Glenmark Pharma has recommended buy rating on the stock with a target price of Rs 1850 in its research report dated August 16, 2024.

  • Buy Glenmark Pharmaceuticals; target of Rs 1894: KR Choksey

    Buy Glenmark Pharmaceuticals; target of Rs 1894: KR Choksey

    KR Choksey is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1894 in its research report dated August 20, 2024.

  • Buy Glenmark Pharma; target of Rs 1403: KR Choksey

    Buy Glenmark Pharma; target of Rs 1403: KR Choksey

    KR Choksey is bullish on Glenmark Pharma has recommended buy rating on the stock with a target price of Rs 1403 in its research report dated June 03, 2024.

  • Neutral Glenmark Pharma; target of Rs 1050: Motilal Oswal

    Neutral Glenmark Pharma; target of Rs 1050: Motilal Oswal

    Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 1050 in its research report dated May 27, 2024.

  • Buy Glenmark Pharmaceuticals; target of Rs 1266: KR Choksey

    Buy Glenmark Pharmaceuticals; target of Rs 1266: KR Choksey

    KR Choksey is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1266 in its research report dated April 05, 2024.

  • Accumulate Glenmark Pharmaceuticals; target of Rs 984: KR Choksey

    Accumulate Glenmark Pharmaceuticals; target of Rs 984: KR Choksey

    KR Choksey recommended Accumulate rating on Glenmark Pharmaceuticals with a target price of Rs 984 in its research report dated February 22, 2024.

  • Neutral Glenmark Pharma; target of Rs 780: Motilal Oswal

    Neutral Glenmark Pharma; target of Rs 780: Motilal Oswal

    Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 780 in its research report dated August 14, 2023.

  • Neutral Glenmark Pharma; target of Rs 580: Motilal Oswal

    Neutral Glenmark Pharma; target of Rs 580: Motilal Oswal

    Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 580 in its research report dated May 22, 2023.

  • Reduce Glenmark Pharmaceuticals; target of Rs 570: Prabhudas Lilladher

    Reduce Glenmark Pharmaceuticals; target of Rs 570: Prabhudas Lilladher

    Prabhudas Lilladher recommended reduce rating on Glenmark Pharmaceuticals with a target price of Rs 570 in its research report dated May 23, 2023.

  • Accumulate Glenmark Pharmaceuticals; target of Rs 460: Prabhudas Lilladher

    Accumulate Glenmark Pharmaceuticals; target of Rs 460: Prabhudas Lilladher

    Prabhudas Lilladher recommended accumulate rating on Glenmark Pharmaceuticals with a target price of Rs 460 in its research report dated February 14, 2023.

  • Neutral Glenmark Pharma; target of Rs 420: Motilal Oswal

    Neutral Glenmark Pharma; target of Rs 420: Motilal Oswal

    Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 420 in its research report dated November 14, 2022.

  • Hold Glenmark Pharmaceuticals; target of Rs 470: ICICI Direct

    Hold Glenmark Pharmaceuticals; target of Rs 470: ICICI Direct

    ICICI Direct recommended hold rating on Glenmark Pharmaceuticals with a target price of Rs 470 in its research report dated November 21, 2022.

  • Accumulate Glenmark Pharmaceuticals; target of Rs 460: Prabhudas Lilladher

    Accumulate Glenmark Pharmaceuticals; target of Rs 460: Prabhudas Lilladher

    Prabhudas Lilladher recommended accumulate rating on Glenmark Pharmaceuticals with a target price of Rs 460 in its research report dated November 19, 2022.

  • Neutral Glenmark Pharma; target of Rs 420 : Motilal Oswal

    Neutral Glenmark Pharma; target of Rs 420 : Motilal Oswal

    Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 420 in its research report dated November 17, 2022.

  • Accumulate Glenmark Pharma; target of Rs 433: KR Choksey

    Accumulate Glenmark Pharma; target of Rs 433: KR Choksey

    KR Choksey recommended accumulate rating on Glenmark Pharma with a target price of Rs 433 in its research report dated August 16, 2022.

  • Hold Glenmark Pharmaceuticals; target of Rs 440: ICICI Direct

    Hold Glenmark Pharmaceuticals; target of Rs 440: ICICI Direct

    ICICI Direct recommended hold rating on Glenmark Pharmaceuticals with a target price of Rs 440 in its research report dated August 16, 2022.

  • Neutral Glenmark Pharma; target of Rs 420: Motilal Oswal

    Neutral Glenmark Pharma; target of Rs 420: Motilal Oswal

    Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 420 in its research report dated August 12, 2022.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347